Evaluation of a radioreceptor assay to assess exogenous estrogen activity in serum of patients with breast cancer.
A radioreceptor assay (RRA) for the determination of total estrogen activity, was set up and used to assess the possible presence of exogenous molecules with estrogen activity in serum; a comparison was made with the specific radioimmunoassay (RIA) for the endogenous estrogen 17-B estradiol (17-B-E2). The assay was first performed on sera from healthy people taking estrogens in the form of oral contraceptives or lotions for local application whose total estrogenic activity in the blood was assumed to be abnormal. The assay was then performed on serum from 98 patients with early breast cancer and 20 patients with metastasis, not undergoing hormone therapy. A higher estrogen activity was found in 2.5% of sera compared to the activity found using the RIA method which is specific for endogenous estrogen 17-B-E2, the RRA/17-B-E2 ratio being higher than 3. Increased estrogen activity was found in 10% serum samples from digoxin treated cardiopathic patients, with an RRA/17-B-E2 ratio ranging from 4.4 to 20. The RRA assay could prove useful for showing up exogenous estrogen activity from various sources (drugs, food) in sera of people in whom estrogen stimulation could be potentially dangerous (i.e. in patients with hormone-sensitive tumors). This exogenous activity could support a certain degree of neoplastic stimulation and, therefore, unfavourably condition the patients' therapeutic response.
Di Lorenzo
D
D
Cattedra di Chimica e Propedeutica Biochimica, Facoltà di Medicina e Chirurgia, Università di Brescia, Italy.
Ruggeri
G
G
Iacobello
C
C
Belloli
S
S
Gion
M
M
Zava
D T
DT
Ghielmi
S
S
Albertini
A
A
D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy; D004077:Digoxin / Q000097:blood / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000097:blood*; D005069:Evaluation Studies as Topic; D005260:Female; D006331:Heart Diseases / Q000097:blood / Q000188:drug therapy; D006801:Humans; D011863:Radioimmunoassay / Q000379:methods; D011869:Radioligand Assay / Q000379:methods*; D013629:Tamoxifen / Q000097:blood / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D004967:Estrogens; D013629:Tamoxifen; D004958:Estradiol; D004077:Digoxin